First Commonwealth Financial Corp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,015
| Closed | -$245K | – | 228 |
|
|
2025
Q1 | $245K | Hold |
4,015
| – | – | 0.06% | 208 |
|
|
2024
Q4 | $227K | Buy |
+4,015
| New | +$224K | 0.05% | 203 |
|
|
2024
Q3 | – | Sell |
-11,815
| Closed | -$491K | – | 204 |
|
|
2024
Q2 | $491K | Sell |
11,815
-1,471
| -11% | -$65.8K | 0.13% | 154 |
|
|
2024
Q1 | $720K | Buy |
13,286
+8,639
| +186% | +$440K | 0.19% | 112 |
|
|
2023
Q4 | $238K | Sell |
4,647
-3,170
| -41% | -$166K | 0.07% | 156 |
|
|
2023
Q3 | $454K | Hold |
7,817
| – | – | 0.15% | 117 |
|
|
2023
Q2 | $500K | Buy |
7,817
+494
| +7% | +$33.1K | 0.16% | 112 |
|
|
2023
Q1 | $508K | Sell |
7,323
-222
| -3% | -$15.7K | 0.18% | 113 |
|
|
2022
Q4 | $543K | Sell |
7,545
-572
| -7% | -$43.1K | 0.2% | 107 |
|
|
2022
Q3 | $577K | Sell |
8,117
-901
| -10% | -$65.4K | 0.24% | 84 |
|
|
2022
Q2 | $695K | Sell |
9,018
-8,812
| -49% | -$671K | 0.26% | 80 |
|
|
2022
Q1 | $1.3M | Buy |
17,830
+440
| +3% | +$29.5K | 0.42% | 46 |
|
|
2021
Q4 | $1.08M | Buy |
17,390
+25
| +0.1% | +$1.47K | 0.35% | 56 |
|
|
2021
Q3 | $1.03M | Sell |
17,365
-148
| -0.8% | -$9.75K | 0.37% | 54 |
|
|
2021
Q2 | $1.17M | Buy |
17,513
+516
| +3% | +$33.6K | 0.41% | 46 |
|
|
2021
Q1 | $1.07M | Sell |
16,997
-2,256
| -12% | -$140K | 0.42% | 49 |
|
|
2020
Q4 | $1.19M | Sell |
19,253
-3,562
| -16% | -$219K | 0.52% | 38 |
|
|
2020
Q3 | $1.38M | Buy |
22,815
+3,333
| +17% | +$201K | 0.64% | 31 |
|
|
2020
Q2 | $1.15M | Buy |
19,482
+2,267
| +13% | +$136K | 0.54% | 33 |
|
|
2020
Q1 | $960K | Buy |
17,215
+3,032
| +21% | +$185K | 0.58% | 29 |
|
|
2019
Q4 | $910K | Buy |
14,183
+53
| +0.4% | +$3.04K | 0.49% | 42 |
|
|
2019
Q3 | $716K | Buy |
14,130
+4,185
| +42% | +$197K | 0.43% | 49 |
|
|
2019
Q2 | $451K | Buy |
9,945
+5,661
| +132% | +$264K | 0.28% | 84 |
|
|
2019
Q1 | $205K | Sell |
4,284
-450
| -10% | -$22.4K | 0.13% | 137 |
|
|
2018
Q4 | $246K | Sell |
4,734
-2,047
| -30% | -$110K | 0.17% | 114 |
|
|
2018
Q3 | $421K | Sell |
6,781
-4,392
| -39% | -$261K | 0.28% | 93 |
|
|
2018
Q2 | $618K | Sell |
11,173
-108
| -1% | -$5.83K | 0.64% | 44 |
|
|
2018
Q1 | $714K | Buy |
11,281
+7,663
| +212% | +$493K | 0.75% | 39 |
|
|
2017
Q4 | $222K | Sell |
3,618
-2,304
| -39% | -$144K | 0.23% | 113 |
|
|
2017
Q3 | $377K | Sell |
5,922
-2,720
| -31% | -$159K | 0.43% | 76 |
|
|
2017
Q2 | $482K | Buy |
+8,642
| New | +$470K | 0.53% | 72 |
|
Other funds holding BMY
First Commonwealth Financial Corp's BMY Position: Q2 2025 in Review
First Commonwealth Financial Corp sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,015 shares — an estimated $245K sold.
First Commonwealth Financial Corp first reported a position in BMY in Q2 2017 and held it in 31 quarters. The position peaked at $1.38M in Q3 2020. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- First Commonwealth Financial Corp reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- First Commonwealth Financial Corp sold 4,015 Bristol-Myers Squibb shares in Q2 2025, an estimated $245K.
- First Commonwealth Financial Corp first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 31 quarters.
- First Commonwealth Financial Corp's Bristol-Myers Squibb position peaked at $1.38M in Q3 2020.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on First Commonwealth Financial Corp's 13F filing for Q2 2025, filed 14 Aug 2025.